01 1Alivus Life Sciences
01 1NINTEDANIB ESYLATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-11-05
Pay. Date : 2019-10-10
DMF Number : 32152
Submission : 2017-12-28
Status : Active
Type : II
20
Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NINTEDANIB ESYLATE, with a corresponding US DMF Number 32152.
Remarkably, this DMF maintains an Active status since its submission on December 28, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 05, 2019, and payment made on October 10, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
